14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Jul 25, 2022 $0.384 $0.384 $0.370 $0.375 921 623
Jul 22, 2022 $0.388 $0.389 $0.370 $0.386 1 276 286
Jul 21, 2022 $0.399 $0.399 $0.378 $0.390 1 005 593
Jul 20, 2022 $0.400 $0.410 $0.370 $0.380 3 156 430
Jul 19, 2022 $0.375 $0.398 $0.365 $0.396 3 328 003
Jul 18, 2022 $0.374 $0.374 $0.348 $0.364 2 788 992
Jul 15, 2022 $0.380 $0.381 $0.347 $0.354 4 689 488
Jul 14, 2022 $0.395 $0.399 $0.360 $0.373 5 286 696
Jul 13, 2022 $0.430 $0.430 $0.385 $0.390 9 715 133
Jul 12, 2022 $0.84 $0.87 $0.84 $0.85 932 829
Jul 11, 2022 $0.90 $0.90 $0.82 $0.86 1 133 900
Jul 08, 2022 $0.86 $0.89 $0.86 $0.89 131 289
Jul 07, 2022 $0.85 $0.87 $0.84 $0.86 96 729
Jul 06, 2022 $0.80 $0.83 $0.80 $0.81 120 262
Jul 05, 2022 $0.82 $0.84 $0.794 $0.81 164 974
Jul 01, 2022 $0.780 $0.790 $0.770 $0.780 139 682
Jun 30, 2022 $0.750 $0.783 $0.730 $0.770 225 932
Jun 29, 2022 $0.760 $0.790 $0.745 $0.761 288 416
Jun 28, 2022 $0.737 $0.758 $0.700 $0.746 280 696
Jun 27, 2022 $0.725 $0.750 $0.700 $0.735 332 808
Jun 24, 2022 $0.82 $0.84 $0.580 $0.617 1 241 373
Jun 23, 2022 $0.82 $0.85 $0.786 $0.82 124 421
Jun 22, 2022 $0.81 $0.85 $0.80 $0.82 693 572
Jun 21, 2022 $0.83 $0.85 $0.81 $0.82 179 179
Jun 17, 2022 $0.780 $0.83 $0.780 $0.790 209 252
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT